Literature DB >> 10841317

Endometrial-myometrial interface: relationship to adenomyosis and changes in pregnancy.

A S Uduwela1, M A Perera, L Aiqing, I S Fraser.   

Abstract

The endometrial-myometrial interface (EMI) is an important region of the human uterus, which has attracted little research attention. This mucosal-muscular interface has characteristic features when compared with other similar interfaces in the human body. It lacks an intervening tissue layer and as a result, the endometrium sits directly on the myometrium rendering it vulnerable to invasion by the endometrium. Both endometrium and myometrium are sensitive to sex steroids, and their structure and function depend to a large extent on the sex hormonal milieu. Endometrium, which forms one border of the EMI, is a complex tissue consisting of several polarized microenvironments. At a cellular level, sex steroids interact with local mediators secreted by a variety of cell types and are important in maintaining the complex structure and function of the endometrium. Basal endometrium contains prominent aggregates of leukocytes that may be important in controlling local cell growth and function. Myometrium also has a distinct zonal anatomy. The recently described junctional zone differs structurally and functionally from the outer myometrium, although these functions are not yet clearly understood. Embryologically, it originates from müllerian ducts together with endometrium, whereas the outer myometrium has a non-müllerian origin. During early pregnancy, the EMI is disturbed by invading trophoblast. Alterations of myometrial intercellular matrix proteins together with expression of appropriate receptors by the trophoblast seem to regulate this unique interaction. The EMI also is disrupted in adenomyosis. The sequence of events taking place at the EMI during development of this pathology is still debated.

Entities:  

Mesh:

Year:  2000        PMID: 10841317     DOI: 10.1097/00006254-200006000-00025

Source DB:  PubMed          Journal:  Obstet Gynecol Surv        ISSN: 0029-7828            Impact factor:   2.347


  20 in total

1.  In vivo high-resolution magnetic resonance elastography of the uterine corpus and cervix.

Authors:  Xuyuan Jiang; Patrick Asbach; Kaspar-Josche Streitberger; Anke Thomas; Bernd Hamm; Jürgen Braun; Ingolf Sack; Jing Guo
Journal:  Eur Radiol       Date:  2014-07-21       Impact factor: 5.315

2.  Adenomyosis: Mechanisms and Pathogenesis.

Authors:  Junyu Zhai; Silvia Vannuccini; Felice Petraglia; Linda C Giudice
Journal:  Semin Reprod Med       Date:  2020-10-08       Impact factor: 1.303

3.  L-22 enhances the invasiveness of endometrial stromal cells of adenomyosis in an autocrine manner.

Authors:  Qing Wang; Li Wang; Jun Shao; Yan Wang; Li-Ping Jin; Da-Jin Li; Ming-Qing Li
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

4.  Blocking IL-22, a potential treatment strategy for adenomyosis by inhibiting crosstalk between vascular endothelial and endometrial stromal cells.

Authors:  Wen-Qing Shang; Jia-Jun Yu; Lei Zhu; Wen-Jie Zhou; Kai-Kai Chang; Qing Wang; Ming-Qing Li
Journal:  Am J Transl Res       Date:  2015-10-15       Impact factor: 4.060

5.  Stem cells in endometrium and their role in the pathogenesis of endometriosis.

Authors:  Paula Gabriela Marin Figueira; Mauricio Simões Abrão; Graciela Krikun; Hugh S Taylor; Hugh Taylor
Journal:  Ann N Y Acad Sci       Date:  2011-03       Impact factor: 5.691

6.  Endometriosis: A Retrospective Analysis of Clinical Data from a Cohort of 4,083 Patients, With Focus on Symptoms.

Authors:  Pietro G Signorile; Maria Cassano; Rosa Viceconte; Valentina Marcattilj; Alfonso Baldi
Journal:  In Vivo       Date:  2022 Mar-Apr       Impact factor: 2.155

7.  Establishment of a novel mouse model of adenomyosis suitable for longitudinal and quantitative analysis and perinatal outcome studies.

Authors:  Mohammed Elsherbini; Kaori Koga; Takehiro Hiraoka; Keiichi Kumasawa; Eiko Maki; Erina Satake; Ayumi Taguchi; Tomoko Makabe; Arisa Takeuchi; Gentaro Izumi; Masashi Takamura; Miyuki Harada; Tetsuya Hirata; Yasushi Hirota; Osamu Wada-Hiraike; Yutaka Osuga
Journal:  Sci Rep       Date:  2022-10-20       Impact factor: 4.996

8.  Coexistence of adenomyosis, adenocarcinoma, endometrial and myometrial lesions in resected uterine specimens.

Authors:  Seza Tetikkurt; Elif Çelik; Hazal Taş; Tuğçe Cay; Selman Işik; Abdullah Taner Usta
Journal:  Mol Clin Oncol       Date:  2018-06-18

9.  β-Catenin activation contributes to the pathogenesis of adenomyosis through epithelial-mesenchymal transition.

Authors:  Seo Jin Oh; Jung-Ho Shin; Tae Hoon Kim; Hee Sun Lee; Jung-Yoon Yoo; Ji Yeon Ahn; Russell R Broaddus; Makoto M Taketo; John P Lydon; Richard E Leach; Bruce A Lessey; Asgerally T Fazleabas; Jeong Mook Lim; Jae-Wook Jeong
Journal:  J Pathol       Date:  2013-10       Impact factor: 7.996

10.  Effects of Jiawei Shaoyao-Gancao Decoction and Its Drug-Containing Serum on Proliferation, Apoptosis, and Ultrastructure of Human Adenomyosis Foci Cells.

Authors:  Yu-Yan Zeng; Kun-Yin Li
Journal:  Evid Based Complement Alternat Med       Date:  2017-09-12       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.